XML 44 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Narrative (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
segment
installment
Sep. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2016
USD ($)
New Accounting Pronouncement, Early Adoption [Line Items]                    
Restricted cash $ 100,000   $ 100,000       $ 100,000      
Joint venture quarterly promotion fee cap         10.00% 10.00%        
Revenue 12,251,000 $ 10,775,000 35,610,000 $ 29,307,000            
Advertising expense 600,000 300,000 $ 1,300,000 900,000            
Dividend yield     0.00%              
Number of operating segments | segment     1              
Janssen Promotion Agreement                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Termination of agreement 600,000   $ 600,000              
Restricted stock units                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Period, Number Of Annual Installments | installment     4              
Janssen (SIMPONI)                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Revenue 400,000 1,300,000 $ 1,000,000.0 3,400,000            
Minimum                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Joint venture, quarterly promotion fee per prescription         $ 500 $ 500   $ 750 $ 750  
Joint venture, quarterly promotion fee         300,000 300,000        
Maximum                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Joint venture, quarterly promotion fee per prescription         $ 1,000 $ 1,000   $ 1,250 $ 1,250  
Other assets                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Restricted cash                   $ 100,000
Shipping and Handling                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Cost of revenue $ 600,000 $ 400,000 $ 1,600,000 $ 1,100,000            
Revenue Benchmark | Product Concentration Risk | AVISE CTD Test                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Percent of total revenue 81.00% 68.00% 81.00% 71.00%            
Revenue Benchmark | Supplier Concentration Risk | Two Major Suppliers                    
New Accounting Pronouncement, Early Adoption [Line Items]                    
Percent of total revenue 95.00% 98.00% 96.00% 97.00%